- Home
- HFBL vs ANTX Comparison
HFBL vs ANTX Comparison
Compare HFBL & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- ANTX
- Stock Information
- Founded
- HFBL 1924
- ANTX 2017
- Country
- HFBL United States
- ANTX United States
- Employees
- HFBL N/A
- ANTX N/A
- Industry
- HFBL Savings Institutions
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- HFBL Finance
- ANTX Health Care
- Exchange
- HFBL Nasdaq
- ANTX Nasdaq
- Market Cap
- HFBL 41.7M
- ANTX 37.3M
- IPO Year
- HFBL N/A
- ANTX 2022
- Fundamental
- Price
- HFBL $12.76
- ANTX $1.22
- Analyst Decision
- HFBL
- ANTX Buy
- Analyst Count
- HFBL 0
- ANTX 4
- Target Price
- HFBL N/A
- ANTX $2.00
- AVG Volume (30 Days)
- HFBL 3.0K
- ANTX 134.1K
- Earning Date
- HFBL 05-01-2025
- ANTX 05-16-2025
- Dividend Yield
- HFBL 4.08%
- ANTX N/A
- EPS Growth
- HFBL N/A
- ANTX N/A
- EPS
- HFBL 1.09
- ANTX N/A
- Revenue
- HFBL $20,019,000.00
- ANTX N/A
- Revenue This Year
- HFBL N/A
- ANTX N/A
- Revenue Next Year
- HFBL N/A
- ANTX N/A
- P/E Ratio
- HFBL $11.70
- ANTX N/A
- Revenue Growth
- HFBL N/A
- ANTX N/A
- 52 Week Low
- HFBL $10.60
- ANTX $0.87
- 52 Week High
- HFBL $14.08
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- HFBL 40.83
- ANTX 45.46
- Support Level
- HFBL $12.86
- ANTX $1.05
- Resistance Level
- HFBL $13.39
- ANTX $1.29
- Average True Range (ATR)
- HFBL 0.07
- ANTX 0.07
- MACD
- HFBL -0.07
- ANTX -0.00
- Stochastic Oscillator
- HFBL 1.22
- ANTX 61.82
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.